FDAnews Drug Daily Bulletin

LUBRIZOL SELLS ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATE COMPOUNDS BUSINESS

April 3, 2006
A A

The Lubrizol Corporation announced today that it has agreed to sell its active pharmaceutical ingredient and intermediate compounds business, with facilities in Raubling, Germany and Chennai, India (A&I). The purchasers are Auctus Management GmbH (Auctus), a German private equity firm located in Munich, Germany, and the current management of the active pharmaceutical ingredient business. KeyBanc Capital Markets advised Lubrizol on the transaction. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-31-2006/0004330756&EDATE=)